Perceptions of Management Issues in Biotechnology in Thailand - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

Perceptions of Management Issues in Biotechnology in Thailand

Description:

healthcare industry (at least 2 companies) pharmaceutical industry (at least 2 companies) 3 managers from each company listed above ... – PowerPoint PPT presentation

Number of Views:59
Avg rating:3.0/5.0
Slides: 20
Provided by: stcArts
Category:

less

Transcript and Presenter's Notes

Title: Perceptions of Management Issues in Biotechnology in Thailand


1
Perceptions of Management Issues in Biotechnology
in Thailand
  • A Presentation for
  • by
  • Associate Prof. Siriyupa Roongrerngsuke, Ph. D.
  • Sarote Phornprapha, Ph.D.
  • for
  • Eighth Asian Bioethics Confernece (ABC 2007)

2
Current Situation of Biotechnology in Developing
Countries
  • Global system governing biotechnology has
    dominantly been shaped by Western hopes and fears
    and more research is needed to explore how
    developing countries view this technology.
  • Few surveys have been conducted in developing
    countries to clarify how biotechnology is
    understood, perceived, and discussed.
  • Oversimplification of the risks and benefits of
    biotechnology
  • Ineffective, inefficient, or even irresponsible
    management of biotech business

Aerni, 2004
3
Research Objectives
  • To investigate the issues/topics to be included
    in the development of a curriculum of the course,
    Principles of Biotechnology Management for
    students of Master Degree in Biotechnology
    Management Program for the first time in Thailand.

4
Research Methodologies
  • Literature survey on related topics which
    includes
  • corporate governance
  • biotechnology companies Vs. ethical issues
  • the stakeholder concept in biotechnology
  • management issues in biotechnology
  • Development of a draft of Principles of
    Management for Biotechnology Course Curriculum
  • Survey of perceptions and comments on issues to
    be included in the curriculum designed for the
    course Principles of Management in
    Biotechnology as drafted by the researchers. The
    methods to be used to survey the perceptions are
  • Individual interview
  • Focus group interview

5
Research Methodologies
  • Populations
  • Individual interview Interviews were be
    conducted to explore perceptions and comments
    from
  • 3 experts in academia in biotechnology from
    leading universities/institutes in Thailand
  • 8 top management from leading biotechnology
    companies in Thailand (preferably those listed in
    the SET) which include
  • agricultural industry (at least 2 companies)
  • food industry (at least 2 companies)
  • healthcare industry (at least 2 companies)
  • pharmaceutical industry (at least 2 companies)
  • 3 managers from each company listed above

6
Researcher Methodologies
  • Focus group interview Interviews were conducted
    to explore perceptions and comments from 24
    managers working in non-biotechnology companies
    and 25 from managers of non-biotech companies
  • Interviews were conducted to survey general
    awareness and perception of 50 people
    representing the public regarding biotechnology
    industry and management issues in biotechnology
    industry in Thailand.

7
Review of Related LiteratureTopics involved in
the design of an appropriate curriculum for
biotechnology management
  • Corporate governance, business ethics and
    bioethics
  • How biotechnology companies are currently dealing
    with bioethical issues
  • The stakeholder concept in biotechnology
  • Fundamental issues in management course

8
What is Corporate Governance?
  • Corporate governance refers to the private and
    public institutions, including laws, regulations
    and accepted business practices, which together
    govern the relationship, in a market economy,
    between corporate managers and entrepreneurs
    (corporate insiders) on one hand, and those who
    invest resources in corporations, on the other.
  • Investors can include suppliers of equity
    finance (shareholders, suppliers of debt finance
    (creditors), suppliers of other tangible and
    intangible assets that corporations may use to
    operate and grow.
  • (Oman, 1999)

9
How biotech companies are dealing with ethical
issues?
  • Kato and Macer (2003) conducted a survey of 559
    biotech companies in USA, UK, France, Canada, and
    Germany about how they respond to bioethical
    issues.
  • Study reveals that companies respond to the
    issues differently and among those 559 companies,
    only 11 per cent of companies reported that they
    had codes of ethics, another 11 per cent had a
    policy or policy statement on ethical issues, and
    5 per cent had only general codes of conduct not
    especially about bioethics.

10
The Stakeholder Concept in Biotechnology
  • Freeman (2001), a renowned scholar in the field
    of business ethics views that stakeholders
    simply refer to those groups who have a stake in
    or claim on the firm including suppliers,
    customers, employees, stockholders, and the
    firms local community.
  • Stakeholder analysis can provide biotechnology
    companies with a lens through which to pay
    attention to the full range of interested
    parties. (MacDonald, 2004)

11
Management Issues in Biotechnologty
  • Fundamental knowledge of principles of management
    and strategic management for biotechnology
    industry
  • Fundamental knowledge in biotechnology
  • Understanding entrepreneurial mindset in startup
    and large companies.
  • Finance financing for biotechnology business,
    grant proposal strategies and management
  • Marketing market analysis, marketing strategies
    for biotech products

12
  • Regulatory issues in biotechnology industry such
    as clinical trial process for both devices and
    drugs in biomedical technology, FDA approvals.
  • Intellectual property issues and
    commercialization
  • Project management
  • Product development and transition to business
    units
  • Bioethics and legal issues
  • Stakeholder analysis and corporate governance

13
Results
  • OVERALL RESULTS
  • Most respondents agree that there is a need for
    the development of biotechnology management
    course to prepare managers to be fluent in the
    following areas
  • Fundamentals of management, strategic management,
    entrepreneurship in biotech industry
  • Marketing of biotech invention
  • Financial management and grant management
  • Management for invention and innovation
  • Corporate governance for biotech business
    (bioethics and legal issues)
  • Intellectual property of biotech products
  • Managing conflicts of interests and safety issues
    in biotech companies
  • Creating and managing human resource in biotech
    business
  • Among these eight areas, the marketing of biotech
    invention appears to be the area that respondents
    deem the most important area to be offered in the
    curriculum

14
Issues Perceived by Biotech-based Managers
  • Fundamentals of management, strategic management,
    entrepreneurship in biotech industry
  • Intellectual property of biotech products
  • Corporate governance for biotech business
    (bioethics and legal issues)
  • Marketing of biotech invention
  • Financial management and grant management
  • Management for invention and innovation
  • Managing conflicts of interests and safety issues
    in biotech companies
  • Creating and managing human resource in biotech
    business

15
Issues Perceived by Non-Biotech Managers
  • Fundamentals of management, strategic management,
    entrepreneurship in biotech industry
  • Marketing of biotech invention
  • Financial management and grant management
  • Management for invention and innovation
  • Intellectual property of biotech products
  • Corporate governance for biotech business
    (bioethics and legal issues)
  • Managing conflicts of interests and safety issues
    in biotech companies
  • Creating and managing human resource in biotech
    business

16
Other Issues from Experts in Biotech
  • Biotech is a very important field and mechanism
    to drive national development and growth
  • Lack of understanding and adequate support from
    Government
  • Problems of legal issues
  • Lack of understanding and awareness of biotech
    from the public make it difficult to receive fund
    and support
  • Good management is really needed

17
Other Issues from Managers of Non-Biotech
  • 90 of managers in the non-biotech companies are
    not familiar with the term biotechnology, and
    are not certain about what the term really means.
    They are not certain if they know the biotech
    products and/or inventions as existing and/or
    available in the daily life.

18
Other Issues from the Public
  • 78 never heard of the term biotechnology
  • 11 heard of the term biotechnology but do not
    know the meaning
  • 11 heard of the term and understand the meaning
    and importance of biotech

19
Summary Recommendations
  • Public needs to be educated about biotech.
  • Management knowledge in biotech industry is
    perceived as very important
  • Prior to the dissemination of biotech management
    knowledge, awareness of the field must be created.
Write a Comment
User Comments (0)
About PowerShow.com